Off-Label Communication Policy ‘Speech-Enabling,’ FDA Legal Memo States

The US FDA says in a legal memo that its new guidance on scientific information on unapproved uses (SIUU) is “speech-enabling” and argues that challenges should be interpreted as attempts to roll back the approval process.

Dolls on laptop keyboard in front of screen reading "Freedom of Speech."
(Muhd Imran Ismael/Shutterstock)
Michael McCaughan

Read more by Michael McCaughan

Michael McCaughan is a founding member of Prevision Policy LLC, a leading provider of regulatory and reimbursement policy analysis for the biopharma industry. He was previously the Editor-In-Chief of The Pink Sheet and remains a contributor to the publication.

More from Medtech Insight

More from Legal & IP